Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-16

FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva Pharmaceuticals USA, Inc.'s supplemental application for Clozapine (generic) under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)